---
title: Reporting of adverse events
author: Steve Simon
date: 2008-08-05
category:
- Blog post
tags:
- Adverse events in clinical trials
output: html_document
---
Most Institutional Review Boards (IRBs) have difficulty coping with the
volume of adverse events that study sponsors report to them. The FDA
held a public meeting about this issue recently, and some written
responses are available as PDF files at the following location:

-   [www.fda.gov/ohrms/dockets/dockets/05n0038/mostrecent.htm](http://www.fda.gov/ohrms/dockets/dockets/05n0038/mostrecent.htm)

You can find an [earlier version](http://www.pmean.com/05/AdverseEvents.html) of this page on my [original website](http://www.pmean.com/original_site.html).
